Prestige Consumer Healthcare Inc. (PBH) is a publicly traded Healthcare sector company. As of May 21, 2026, PBH trades at $46.40 with a market cap of $2.21B and a P/E ratio of 12.04. PBH moved +1.96% today. Year to date, PBH is -24.46%; over the trailing twelve months it is -46.11%. Its 52-week range spans $42.62 to $90.04. Analyst consensus is strong buy with an average price target of $82.89. Rallies surfaces PBH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns PBH stock?
Hedge funds tracked by Rallies that own PBH include Eisler Capital and Bridgewater Associates. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Prestige Consumer Healthcare Inc..
PBH Key Metrics
Key financial metrics for PBH
Metric
Value
Price
$46.40
Market Cap
$2.21B
P/E Ratio
12.04
EPS
$3.93
Dividend Yield
0.31%
52-Week High
$90.04
52-Week Low
$42.62
Volume
120
Avg Volume
0
Revenue (TTM)
$1.09B
Net Income
$190.30M
Gross Margin
54.70%
Top Hedge Funds Holding PBH
Eisler Capital holds 11.84K shares of PBH, changed +20.04% as of Jun 30, 2024.
Bridgewater Associates holds 9.66K shares of PBH, changed +0.00% as of Sep 30, 2025.
Hedge funds tracked by Rallies that own PBH include Eisler Capital and Bridgewater Associates. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Prestige Consumer Healthcare Inc..
Does Rallies show 13F holders for PBH?
Yes. Rallies tracks hedge fund and 13F ownership data for PBH, including fund names, share counts, latest tracked quarter, and position changes when available.
Is PBH research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PBH. It does not provide personalized investment advice.
